AIkido Pharma Inc. (AIKI) has 27 open-market insider trades by 3 insiders since 2021. The most active filer is Anthony Hayes, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Soo Yu | Dir | — | 6 | $1.0M | 2022-12-16 |
| Anthony Hayes | CEO | — | 11 | $935K | 2022-12-14 |
| Kyle Michael Wool | Dir | — | 10 | $904K | 2022-12-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Kyle Michael Wool | Director | Buy | $18K | 2022-12-19 |
| Soo Yu | Director | Buy | $19K | 2022-12-16 |
| Kyle Michael Wool | Director | Buy | $18K | 2022-12-15 |
| Anthony Hayes | CEO | Buy | $17K | 2022-12-14 |
| Anthony Hayes | CEO | Buy | $19K | 2022-12-13 |
| Kyle Michael Wool | Director | Buy | $18K | 2022-12-12 |
Companies that share insiders with AIKI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Anthony Hayes | CEO | Buy | $18K | 2022-12-09 |
| Anthony Hayes | CEO | Buy | $18K | 2022-12-08 |
| Anthony Hayes | CEO | Buy | $17K | 2022-12-07 |
| Soo Yu | Director | Buy | $23K | 2022-09-16 |
| Kyle Michael Wool | Director | Buy | $18K | 2022-09-14 |
| Soo Yu | Director | Buy | $9K | 2022-09-14 |
| Kyle Michael Wool | Director | Buy | $300K | 2022-09-13 |
| Soo Yu | Director | Buy | $371K | 2022-09-13 |
| Anthony Hayes | CEO | Buy | $315K | 2022-09-13 |